Fulcrum Therapeutics (FULC) Revenue & Revenue Breakdown
Fulcrum Therapeutics Revenue Highlights
Latest Revenue (Y)
$2.81M
Latest Revenue (Q)
$80.00M
Fulcrum Therapeutics Revenue by Period
Fulcrum Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $2.81M | -55.77% |
| 2022-12-31 | $6.34M | -66.90% |
| 2021-12-31 | $19.16M | 117.19% |
| 2020-12-31 | $8.82M | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | - |
Fulcrum Therapeutics generated $2.81M in revenue during NA 2023, up -55.77% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Fulcrum Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $80.00M | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $871.00K | 14.76% |
| 2023-09-30 | $759.00K | -13.75% |
| 2023-06-30 | $880.00K | 198.31% |
| 2023-03-31 | $295.00K | -56.93% |
| 2022-12-31 | $685.00K | -42.10% |
| 2022-09-30 | $1.18M | -37.14% |
| 2022-06-30 | $1.88M | -27.39% |
| 2022-03-31 | $2.59M | -48.75% |
| 2021-12-31 | $5.06M | 2.49% |
| 2021-09-30 | $4.93M | 12.65% |
| 2021-06-30 | $4.38M | -8.52% |
| 2021-03-31 | $4.79M | 13.35% |
| 2020-12-31 | $4.22M | 128.63% |
| 2020-09-30 | $1.85M | -7.60% |
| 2020-06-30 | $2.00M | 166.67% |
| 2020-03-31 | $750.00K | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | - |
Fulcrum Therapeutics generated $80.00M in revenue during Q1 2024, up 100.00% compared to the previous quarter, and up 27118.64% compared to the same period a year ago.
Fulcrum Therapeutics Peer Comparison by Revenue
FULC Revenue FAQ
What is Fulcrum Therapeutics’s yearly revenue?
Fulcrum Therapeutics's yearly revenue for 2023 was $2.8M, representing a decrease of -55.77% compared to 2022. The company's yearly revenue for 2022 was $6.34M, representing a decrease of -66.90% compared to 2021. FULC's yearly revenue for 2021 was $19.16M, representing an increase of 117.19% compared to 2020.
What is Fulcrum Therapeutics’s quarterly revenue?
Fulcrum Therapeutics's quarterly revenue for Q1 2024 was $80M, a 100.00% increase from the previous quarter (Q4 2023), and a 8990.91% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $0, a -100.00% decrease from the previous quarter (Q3 2023), and a -100.00% decrease year-over-year (Q4 2022). FULC's quarterly revenue for Q3 2023 was $871K, a 14.76% increase from the previous quarter (Q2 2023), and a 27.15% increase year-over-year (Q3 2022).
What is Fulcrum Therapeutics’s revenue growth rate?
Fulcrum Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -85.36%, and for the last 5 years (2019-2023) was 0%.